Updated:
Bluesight
Bluesight, headquartered in Alexandria, United States, was established in 2011. The company develops medication management solutions utilizing RFID technology...
Bluesight
Bluesight, headquartered in Alexandria, United States, was established in 2011. The company develops medication management solutions utilizing RFID technology to track inventory, minimize waste, and optimize costs. Bluesight has secured $42.9 million in total funding.
General information
Firm type
Asset Manager
Year founded
2012
Location
Region
North America
Country
United States
City
Washington
Corporate office
Washington, United States
Principals
Kevin MacDonald
Co-Founder & CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Bluesight?
Bluesight is an operating company, not an investment firm. Strategic and capital allocation decisions are led by co-founder and CEO Kevin MacDonald, who has guided the company since 2012. Venture capital investors including Baird Capital and Blue Heron Capital hold board seats but do not manage the firm's operations.
How does Bluesight source proprietary deal flow?
Bluesight does not source investment deal flow. It generates revenue through enterprise software sales to hospital systems. Its acquisitions—such as the 2023 Medacist purchase and a 2020 buy of an RFID tag provider—address product gaps identified through existing hospital customer relationships.
Is Bluesight structured as a family office or a venture firm?
Neither. Bluesight is a venture-backed healthcare technology company, not an investment vehicle. It raised outside venture capital from Baird Capital, Blue Heron Capital, and others to fund product development. It operates with a traditional corporate governance structure, not a partnership or fund model.
What investment stages does Bluesight typically target?
Bluesight itself is the target of venture investment, not an investor deploying capital into other companies. Its own fundraising history includes early-stage venture rounds, including a Series A from Baird Capital and a subsequent growth round. The firm does not participate in external investment activity.
Which sectors does Bluesight explicitly avoid?
Bluesight operates exclusively within hospital pharmacy compliance and medication management. It has no product lines in payer analytics, electronic health records, telemedicine, or consumer health. The firm's acquisitions reinforce this narrow hospital-pharmacy focus rather than expanding into adjacent healthcare verticals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: